Drugmaker Pfizer has sold its entire stake in consumer healthcare firm Haleon for approximately 2.5 billion pounds (roughly $3.24 billion), according to sources involved in the transaction.
The deal was executed at a price of 385 pence per share, with institutional investors and Haleon purchasing the shares.
Under the agreement, Haleon – known for brands such as Sensodyne, Panadol, and Advil – will buy back 44 million shares from Pfizer, which was its largest shareholder, while 618 million shares are being sold to institutional investors. This sale represents 7.3% of Haleon’s issued share capital. Haleon was established following the merger of GSK and Pfizer's consumer healthcare businesses in 2019 and was spun off from the British drugmaker in 2022.
Following Pfizer’s divestiture, BlackRock Investment Management (UK) Ltd, a unit of BlackRock, is set to become Haleon’s largest shareholder, holding more than a 5% stake, according to data compiled by LSEG. The deal was coordinated by a team that includes BofA Securities, Citigroup Global Markets Limited, and Goldman Sachs International as joint global coordinators, with Barclays and Deutsche Numis acting as joint bookrunners.
Earlier, GSK – which initially held nearly a 13% stake in Haleon – completed its full exit in May 2024. Haleon, which also manufactures popular painkillers, indicated in February that its revenue and profit growth in 2025 would be weighted towards the second half of the year.
The divestiture underscores Pfizer's strategic decision to refocus its portfolio while enabling Haleon to consolidate its shareholder base as it continues to drive growth in the competitive consumer healthcare market.
Kazakhstan has concluded its first election to the new unicameral Kurultai, with turnout reaching 74.19 per cent, as vote counting begins following...
The Democratic Republic of Congo is set to receive 70,000 doses of the Ebola vaccine Ervebo as health authoriti...
U.S. President Donald Trump has vowed...
Iran on Saturday denounced U.S. plans to announce new sanctions that could put further strain on the Islamic Republic's economy and have an impact on its most important trading partners including China.
A large-scale drone attack has hit Russia's Samara region, damaging facilities and disrupting operations at an Ozon logistics complex, according to regional authorities and the company.
Ukrainian President Volodymyr Zelenskyy has rejected calls for a wartime election, arguing that holding a vote while Russia's full-scale invasion continues would divide the country and undermine national unity.
U.S. President Donald Trump said Iran was not ready to make what he called the "right deal" with Washington as tensions persisted over the war and the Strait of Hormuz.
Start your day informed with AnewZ Morning Brief. Here are the top news stories for the 22nd of August, covering the latest developments.
AnewZ Business Europe, a new weekday programme, takes viewers inside companies driving growth and innovation across the continent, with Brickken CEO Edwin Mata joining the programme for its first episode with host Chief Global Editor Guy Shone. The show airs every Friday.
Once associated mainly with Muslim-majority countries, Islamic finance has become a global industry. Its assets reached around $5.98 trillion in 2024, according to ICD–LSEG, as more countries explore Shariah-compliant finance.
Fuel restrictions have returned to parts of Moscow and the surrounding region, adding another strain to Russia’s economy as refinery outages and rising imports weigh on the rouble.
Azerbaijan exported goods worth $17.372 million to Armenia between January and July 2026, according to data from the State Customs Committee, as commercial ties between the two South Caucasus neighbours showed signs of expansion.
Online fast-fashion platform Shein lost a London copyright lawsuit against rival Temu on Thursday over photographs used to promote some products.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment